Michelle Griffin

HTG Molecular Diagnostics has appointed Michelle Griffin to its board of directors. Griffin currently serves as a board member and chair of the audit committee for Acer Therapeutics. She has previously served as a board member and as audit committee chair for multiple firms since 2016, including PhaseRx, OncoGenex Pharmaceuticals, and Sonus Pharmaceuticals. In addition, Griffin has served in executive roles at OncoGenex, Trubion Pharmaceuticals, Dendreon, and Corixa over the past two decades.